State Drug Price Transparency Reporting

Jan 30, 2020 | 11:00 AM - 12:00 PM ET

Recently, several US states have passed, or are in the process of passing new legislations designed to limit drug costs by requiring reporting on drug prices. This includes disclosure of prices of new products, current Wholesale Acquisition Cost (WAC) prices, and drug price increases. These changes have further complicated the data collection and report generation process, leading to regulatory and pricing pressures.

Register for the Webinar
Login with LinkedIn or Google for a seamless experience
Enter your information

About the Speakers


Timothy Litten,
Director, Pricing Transparency,
FluidEdge Consulting

Rajat Shukla,
Senior Lifesciences Consultant,


Key Takeaways

  • The different types of State Drug Price Transparency laws and their complexities
  • An organizational approach to effectively manage the reporting processes


About the Webinar

In this webinar, we will discuss the challenges around data management, compliance of State Drug Price Transparency laws, and pragmatic approaches for manufacturers to effectively and efficiently manage the complex reporting process.